Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 509-517
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.509
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.509
Figure 1 Clinical course of ulcerative colitis patients treated according to the status of cytomegalovirus antigen.
A flow chart of the clinical courses of the 118 patients according to the strategy based on cytomegalovirus (CMV) antigen status is shown. UC: Ulcerative colitis; CMV Ag: Cytomegalovirus antigenemia assay; PSL: Prednisolone; CAI: Clinical activity index; GCV: Ganciclovir; CNIs: Calcineurin inhibitors; TNF-α: Tumor necrosis factor-α.
- Citation: Inokuchi T, Kato J, Hiraoka S, Suzuki H, Nakarai A, Hirakawa T, Akita M, Takahashi S, Harada K, Okada H, Yamamoto K. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol 2014; 20(2): 509-517
- URL: https://www.wjgnet.com/1007-9327/full/v20/i2/509.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i2.509